Consensus Alkem Laboratories Limited Bombay S.E.

Stocks

539523

INE540L01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:30 2026-09-01 EDT			5-day change	1st Jan Change
5,300.00 ^INR	-1.00%		-0.88%	-3.73%

08-14	Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
08-14	Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Evolution of the Average Target: Alkem Laboratories Limited

Evolution of the Target Price: Alkem Laboratories Limited

Changes in Analyst Recommendations: Alkem Laboratories Limited

7f0de544a597a1d33ebcfbb823fa83._fxWLK3R3Lq7k9P6D4kx1-ufSyHJgFEM9ufwUE2PwSk.qaMTbfqmsv2Jw6uqev5Fr7zKPRWvzhZpx9S_JnzZonCWswFi-6mX_fb4ng~342024d8c16a1c7c0c128b4878610e15

Analysts' recommendations: Alkem Laboratories Limited

05-29	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT
05-29	Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy	MT
02-16	Nomura Adjusts Alkem Laboratories' Price Target to INR6,890 From INR 6,860, Keeps at Buy	MT
02-16	IIFL Upgrades Alkem Laboratories to Buy from Add, Price Target is INR6,300	MT
11-17	Nomura Adjusts Alkem Laboratories' Price Target to INR6,860 From INR6,300, Keeps at Buy	MT
25-08-22	Nomura Adjusts Alkem Laboratories' Price Target to INR6,300 From INR5,430, Keeps at Buy	MT
25-08-13	Jefferies Upgrades Alkem Laboratories to Buy From Underperform, Adjusts Price Target to INR6,000 From INR4,460	MT
25-05-30	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,460 From INR4,580, Keeps at Underperform	MT
25-02-27	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR5,430 From INR5,670	MT
25-02-10	Nomura Adjusts Alkem Laboratories' Price Target to INR5,670 From INR6,097, Keeps at Neutral	MT
25-02-10	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,580 From INR5,080, Keeps at Underperform	MT
24-11-15	Nomura Adjusts Alkem Laboratories' Price Target to INR6,097 From INR6,061, Keeps at Neutral	MT
24-11-14	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,950 From INR5,080, Keeps at Underperform	MT
24-08-14	Nomura Adjusts Alkem Laboratories' Price Target to INR6,061 From INR5,605, Keeps at Neutral	MT
24-08-12	Jefferies Adjusts Alkem Laboratories' Price Target to INR5,080 From INR4,200, Keeps at Underperform	MT
24-05-30	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,200 From INR4,470, Keeps at Underperform	MT
24-02-12	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform	MT
23-11-09	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR4,963 From INR3,632	MT
23-11-08	Jefferies Adjusts Alkem Laboratories’ Price Target to INR3,600 From INR3,550, Keeps at Underperform	MT
23-08-11	Jefferies Adjusts Alkem Laboratories' Price Target to INR3,550 From INR2,800, Keeps at Underperform	MT
23-05-23	Nomura Downgrades Alkem Laboratories to Neutral From Buy, Adjusts Price Target to INR3,632 From INR3,772	MT
23-02-14	Nomura Adjusts Alkem Laboratories' Price Target to INR3,772 From INR3,602, Keeps at Buy	MT
23-02-13	Jefferies Adjusts Alkem Laboratories' Price Target to INR2,800 From INR2,600, Keeps at Underperform	MT
23-01-10	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR3,602 From INR3,487	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+13.69%
	JOHNSON & JOHNSON					+2.5%
	ABBVIE INC.					+7.86%
	ROCHE HOLDING AG					+4.96%
	NOVARTIS AG					+1.22%
	ASTRAZENECA PLC					+31.03%
	AMGEN INC.					-9.63%
	NOVO NORDISK A/S					+5.93%
	GILEAD SCIENCES, INC.					+7.56%
	Average					+7.24%
	Weighted average by Cap.					+8.13%